Boston Scientific Corp. et al. v. Cordis Corp.
Boston Scientific Corp. et al. v. Cordis Corp.
2 PagesCounsel for Boston Scientific retained Mary Woodford, a senior advisor at Cornerstone Research, to provide damages analysis and testimony in the May 2011 damages trial. Retained by Kirkland & Ellis and by Desmarais A U.S. District Court judge in Delaware issued an opinion upholding a May 2011 jury verdict that awarded lost profits and reasonable royalty damages to Boston Scientific in its long-running patent infringement suit against Cordis. Counsel for Boston Scientific retained Mary Woodford, a senior advisor at Cornerstone Research, to provide damages analysis and testimony in the May 2011 damages trial. In late 2009, Cordis introduced a new 2.25 mm drug-eluting stent (DES) that infringed Boston Scientific’s patent. This same patent was previously found infringed by Cordis in September
